Coronary disease & ACS

Prognostic value of global myocardial flow reserve in patients with history of coronary artery bypass grafting

Eur Heart J Cardiovasc ImagingPublished Prospective cohort study

Main findingResult — go to the resultHazard ratio 2.06 95% CI 1.23–3.44

Authors' conclusion

Among patients with a history of CABG, PET-derived global MFR <2 may identify those with a high risk of subsequent cardiovascular events, especially heart failure, independent of cardiovascular risk factors and perfusion data.

Study context

Population
Patients with prior coronary artery bypass grafting (CABG) and a clinical indication for positron emission tomography (PET), Houston Methodist DeBakey Heart and Vascular Center PET registry66% with myocardial flow reserve (MFR) <2
Participants
836 patients
Exposure
Impaired MFR vs preserved MFR
Outcome
Composite of:
  • All-cause death
  • MI/unplanned revascularization
  • HF admissions
Follow-up
Median 12 (IQR 4-24) months
Methodological detailsregistry, single-centre
  • Registry
  • Single-centre

Main finding

As reported in the abstract

Hazard ratio

2.06

95% CI 1.23–3.44

MFR <2vs MFR ≥2
HR 2.06 (95% CI 1.23–3.44)
Incident events, total
122

Observational data: associations, not effects.

Further findings

HF admissions

Impaired MFR associated with higher risk of HF admissions (adjusted; 95% CI 1.11-7.67)
HR 2.92
  • Adjusted analysis

All-cause death

Impaired MFR not significantly associated with all-cause death (adjusted; 95% CI 0.85-4.79)
HR 2.01
  • Adjusted analysis

Myocardial infarction (MI)/unplanned revascularization

Impaired MFR not significantly associated with MI/UR (adjusted; 95% CI 0.92-4.05)
HR 1.93
  • Adjusted analysis

Original publication

Prognostic value of global myocardial flow reserve in patients with history of coronary artery bypass grafting. Eur Heart J Cardiovasc Imaging. Published 24 July 2023. doi:10.1093/ehjci/jead120

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.